Please ensure Javascript is enabled for purposes of website accessibility

SEC Filing Details

Document Details

Form
Filing Date
Feb 14, 2022
Document Date
Feb 10, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Apellis Pharmaceuticals, Inc.
Issuer
APELLIS PHARMACEUTICALS, INC.
Filer
Sullivan Timothy Eugene